Interferon-inducible genes are major targets of human papillomavirus type 31 Human papillomavirus (HPVs) are small DNA viruses that infect epithelial tissue. More than 70 subtypes of HPV have been identified to date and they exhibit specific tropism to various region of the body [11, 19, 33] . Genital HPVs can be divided to high-risk and low-risk groups [19] . The high-risk genital HPVs (HPV16, 18, 31, 33, and 54) are the etiological agents of cervical cancer, whereas low-risk HPVs (HPV6 and 11) are associated with common genital warts. Cervical cancer is the second most common cancer in women world wide, resulting in 500,000 new cases and 200,000 death every year. Because of the lack of the access to routine Pap smears, cervical cancer remains a devastating disease in developing countries [15] .
The genome of HPVs encodes only 8 to 10 proteins. The virus must therefore depend on basic cellular machinery to modulate cellular activities in favor of viral replication. As a result, the interaction of viral proteins with the host proteins is essential for viral replication. The best known examples include the interaction of oncoproteins E6 and E7 of high-risk HPVs with p53 and pRB, respectively. These interactions result in degradation and inactivation of p53 by E6 [12, 26, 27] , and inactivation of pRB by E7, resulting in altered regulation of E2F-inducible genes [5, 8, 20] . In addition to E6 and E7, HPV E2 protein has been shown to have transactivation/repression activity by binding to specific recognition sequences [3, 21] , and E5 protein has been shown to enhance signal transduction through the EGF and PDGF receptors [16] . Such alterations are likely to have significant effects on cellular gene expression. An understanding of the virally inducedchanges in cellular gene expression would shed light on HPV viral life cycle and pathogenesis.
The HPV viral life cycle can be divided into at least two stages. The virus establishes latent infection in the basal layer of epidermis following primary infection. Upon keratinocye stratification and differentiation, the viral genome is amplified and late structural genes are synthesized, which leads to virion maturation [7] . Because of the requirement for differentiation at the late stage of viral life cycle, the lack of a good in vitro tissue culture system to propagate the virus has been a major hurdle in HPV research. Recently, a tissue culture model that mimics the latent stage of HPV infection has been developed [7, 23] . Cloned HPV 31 and HPV 18 genome have been used to transfect normal human keratinocytes (NHK) resulting in cell lines that exhibit characteristics of basal keratinocytes infected with HPV. Once induced to differentiate, these cell lines are able to activate late viral functions and produce virions [10, 23] . This system provides an excellent model to investigate virus-cell interactions under physiologically relevant conditions. We have been interested in examining cellular changes at the transcriptional level during the first stage of infection by HPV31. Our experimental approach has been to compare the transcriptional profile of keratinocytes containing transfected HPV31 genome, with that of normal keratinocytes by microarray analysis [13, 32] . In order to avoid any variation resulted from specific genetic background, HPV31 cells were compared with uninfected keratinovytes from the same donor.
Microarray analysis was performed with an array containing 7,075 expressed sequence tags (ESTs), including 4,000 known genes (InCyte Human UniGem V). We observed that expression of most of the ESTs Diff. Expr., Differential Expression. "−" indicates suppression and "+" indicates activation of expression in HPV31 cells.
was not changed by the presence of HPV genes. However, the expression of 178 ESTs (2.5% of total ESTs examined) was increased by between 2 to 3 fold by HPV31, with no activation more than 3.2 fold observed. In addition, the expression of 150 ESTs (2.1%) was decreased by at least two fold in HPV31 cells, with the largest change being 11.5 fold. The annotations of genes that were affected by more than 2.4 fold are listed in Table 1 . The entire list of genes examined and the level of differential expression in normal and in HPV31 cells can be found at http://bugs.mimnet.nwu.edu/laimins lab/chang [4] .
From this analysis, the genes that were up-regulated in HPV31 cells were found to be ESTs with unknown functions, and the small number of known genes that were increased at significant level are also listed in Table 1 . However, the number of genes in that category is not large enough for us to discern any pattern of activation of specific families of genes. Notably, no E2F, or E2F inducible genes were activated significantly in HPV31 cells.
In contrast to genes that were up-regulated, it was simple to identify families of genes down-regulated in HPV31 cells. These can be divided into three categories: genes that are negative regulators of cell growth, genes that are specifically expressed in keratinocytes, and genes that are induced by interferon (IFN). The first category includes p21, Mad and transgelin. The expression of p21 is dependent on p53, and its reduced expression is consistent with the fact that high-risk HPV E6 protein inactivates p53 and thereby reduces the level of p21 expression [9] . Mad interacts with Max and antagonizes the proliferating effect of Myc/Max complex [1] which may play a role in activating telomerase [30] . Transgelin is a gene that is highly expressed in senescent cells, though the function is still not clear [28] . The second category we found to be repressed includes small proline rich protein SPRK, and SprII, defensin, desmocollin 2, desmoplakin, and stratifin [14, 17, 22, 24, 29, 31] . The role of these keratinocyte specific proteins in HPV pathogenesis is not clear. One can envision that by altering the expression of these genes, the cellular environment of the natural host of HPV is therefore changed in terms of response to stress, cell-cell contact, and altered differentiation program.
The third category of genes repressed by HPV includes those involved in the interferon pathway. These genes represent at least 14% of the total genes that were negatively regulated by 2.3 fold or more in HPV31 infected cells. This group includes genes that showed the strongest changes: myxovirus resistance 1 (MxA, 11.5 fold), IFN-α-inducible 11.5 KDa protein (10.1 fold), and IFI 56 (9.6 fold). Among the IFN-inducible genes affected by HPV infection is the major regulator of IFN responsive pathway, Stat-1 (Signal Transducer and Activator of Transcription 1, which was repressed by 3.5 fold) [6] . Down-regulation of the basal level expression of IFN responsive genes in HPV31 cells could be largely the result of reduced basal level of Stat-1 expression. Further analysis has demonstrated that HPV31 cells showed a delayed response to IFN-α in terms of the induction of Stat-1 and MxA RNA. However, upon longer exposure to higher does of IFN-α, the response reached the same level as in uninfected cells. It has been shown that high-risk HPVs interfere with the IFN response in several ways, by blocking interferon synthesis [25] , or by blocking the function of Stat-1 posttranslationally [2, 18] . However, suppression of basal level of Stat-1 expression by HPV has not been reported previously, although Stat-1 activity can be regulated at a post-traslational level. The reduced basal level of Stat-1RNA and protein did provide an advantage for HPV replication by delaying the cellular response to interferon. This delay could be very significant for the virus in evading immune surveillance. It has been postulated that reduced level of Stat-1 may also contribute to tumor progression. We are currently investigating the mechanism of Stat-1 gene suppression. Preliminary data suggested that both Stat-1 promoter inactivation and Stat-1 protein turn over rate may play important roles in regulating Stat-1 activity in HPV31 cells. The role of individual viral genes in these processes is being examined.
These studies demonstrate the utility of applying microarray analysis to HPV positive cells. Such studies can identify new markers of viral infection and potentially prognostic markers of disease progression. A more thorough analysis of biopsy materials and changes induced by other HPV types is needed to make the studies complete.
